Bender, A., W. Koch, M. Elstner, Y. Schombacher, J. Bender, M. Moeschl, F. Gekeler, B. Müller-Myhsok, T. Gasser, K. Tatsch and T. Klopstock: Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial. In: Neurology 67, 7, 1262-1264 (2006).
Linke, R., I. Eisensehr, T. C. Wetter, F. J. Gildehaus, G. Popperl, C. Trenkwalder, S. Noachtar and K. Tatsch: Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease?. In: Movement Disorders 19, 10, 1158-1162 (2004).
Eisensehr, I., R. Linke, K. Tatsch, B. Kharraz, J. F. Gildehaus, C. T. Wetter, C. Trenkwalder, J. Schwarz and S. Noachtar: Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically disorder, Parkinson's disease, and manifest idiopathic REM sleep behavior controls. In: Sleep 26, 5, 507-512 (2003).
Eisensehr, I., R. Linke, K. Tatsch, H. von Lindeiner, B. Kharraz, F. J. Gildehaus, R. Eberle, T. Pollmächer, A. Schuld and S. Noachtar: Alteration of the striatal dopaminergic system in human narcolepsy. In: Neurology 60, 11, 1817-1819 (2003).
Schwarz, J., R. Linke, M. Kerner, P. D. Mozley, C. Trenkwalder, T. Gasser and K. Tatsch: Striatal dopamine transporter binding assessed by I-123 IPT and single photon emission computed tomography in patients with early Parkinson's disease.. In: Archives of Neurology 57, 205-208 (2000).
localid: 25357
Schwarz, J., J. Scherer, C. Trenkwalder, P. D. Mozley and K. Tatsch: Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?. In: Psychiatry Research 83, 23-28 (1998).
localid: 2825
Arnold, G., K. Tatsch, W. H. Oertel, T. Vogl, J. Schwarz, E. Kraft and C. M. Kirsch: Clinical progressive supranuclear palsy: Differential diagnosis by IBZM-SPECT and MRI. In: Journal of Neural Transmission Suppl. 42, 111-118 (1994).
Schwarz, J., A. Antonini, E. Kraft, K. Tatsch, T. Vogl, C. M. Kirsch, K. L. Leenders and W. H. Oertel: Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in the novo Wilson`s disease. In: Neurology 44, 1079-1082 (1994).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.